The first ketamine clinic in the UK has received approval from the Care Quality Commission (CQC) to begin treatments.
UK MP Crispin Blunt raised the question of rescheduling psilocybin in Parliament this week after PM Boris Johnson gave Blunt personal reassurance back in May that...
A philanthropic programme with a focus on the psychedelic sector has been launched to harness the power of innovative mental health approaches for social change.
With limited treatment options available for the condition, one company is setting out to explore the neurogenic potential of psychedelics to combat the cognitive decline of...
Biotech company Cybin has filed an international patent application related to methods for the delivery of psychedelic medications.
Meet Delic, a psychedelic and wellness event and expo for newcomers and veterans in the psychedelics space will take place in AREA15 in Las Vegas, this...
Currently, there is no cure for Parkinson’s Disease, however, certain medications can help improve symtoms.
Real-time quantification of brain activity during the psychedelic experience has been a major barrier within psychedelic research.
Sports luminaries including Mike Tyson will be among the world-leading speakers headlining the largest psychedelic medicine business conference next month.
Seattle council has unanimously voted to pass a resolution to decriminalise entheogenic substances.
Levitee Labs has announced it has listed on the Frankfurt Stock Exchange (FSE).
A free, virtual event is to explore the use of psychedelics for alcohol use disorder and binge drinking.
